Original Research

Published on 15 Feb 2023

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology

in Pharmacology of Anti-Cancer Drugs

Chao Ma
Feng Li
Zhanfeng He
Song Zhao
Yang Yang
Zhuoyu Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1113808

4,181 views
11 citations

Review

Published on 15 Feb 2023

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer

in Pharmacology of Anti-Cancer Drugs

Man Wang
Lijie Zhu
Xiaoxu Yang
Jiahui Li
Yu’e Liu
Ying Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1132158

5,481 views
4 citations

Original Research

Published on 15 Feb 2023

Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking

in Pharmacology of Anti-Cancer Drugs

Qingmin He
Chuan Liu
Xiaohan Wang
Kang Rong
Mingyang Zhu
Liying Duan
Pengyuan Zheng
Yang Mi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1102581

14,981 views
38 citations

Review

Published on 13 Feb 2023

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Lei Jiang
Luan Li
Yongzhuang Liu
Meixiao Zhan
Ligong Lu
Shengtao Yuan
Yanyan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097277

6,371 views
24 citations

Original Research

Published on 13 Feb 2023

Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Sha Cao
Cheng Chen
Dezhi Gu
Zhengdong Wang
Guanghui Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.991881

2,963 views
2 citations

Editorial

Published on 10 Feb 2023

Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification

in Pharmacology of Anti-Cancer Drugs

Yongye Huang
Yue Hou
Peng Qu
Yun Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149777

1,776 views
1 citation

Original Research

Published on 09 Feb 2023

Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma

in Pharmacology of Anti-Cancer Drugs

Shuting Meng
Tianye Zhu
Zhiwei Fan
Yulan Cheng
Yefeng Dong
Fengxu Wang
Xuehai Wang
Deping Dong
Songtao Yuan
Xinyuan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138452

2,380 views
6 citations

Original Research

Published on 09 Feb 2023

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Fengjiao He
Puhua Zeng
Sijing Ma
Ximing Yang
Huan Liu
Qiong Liu
Yangying Zhou
Hong Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1088993

3,071 views
3 citations

Original Research

Published on 09 Feb 2023

Nucleolin recognizing silica nanoparticles inhibit cell proliferation by activating the Bax/Bcl-2/caspase-3 signalling pathway to induce apoptosis in liver cancer

in Pharmacology of Anti-Cancer Drugs

Liangliang Xiang
Yun Li
Xinyu Gu
Shujie Li
Junwei Li
Jinlong Li
Yongxiang Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1117052

2,776 views
3 citations

Original Research

Published on 07 Feb 2023

Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction

in Pharmacology of Anti-Cancer Drugs

Yuanyuan Zheng
Wenjuan Yang
Yewei Jia
Jie Ji
Liwei Wu
Jiao Feng
Yan Li
Ziqi Cheng
Jie Zhang
Jingjing Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1081980

3,735 views
4 citations

Original Research

Published on 06 Feb 2023

A systematic and comprehensive analysis of T cell exhaustion related to therapy in lung adenocarcinoma tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Peipei Hu
Jiahao Ma
Jinjian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1126916

3,572 views
4 citations

Original Research

Published on 06 Feb 2023

Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy

in Pharmacology of Anti-Cancer Drugs

Jie Fu
Xiaoxin Jin
Weidong Chen
Zongyao Chen
Peidong Wu
Wang Xiao
Yuhang Liu
Shuangya Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1083449

2,415 views
1 citation

Original Research

Published on 03 Feb 2023

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy

in Pharmacology of Anti-Cancer Drugs

Claudia Arndt
Antje Tunger
Rebekka Wehner
Rebecca Rothe
Eleni Kourtellari
Stephanie Luttosch
Katharina Hannemann
Stefanie Koristka
Liliana R. Loureiro
Anja Feldmann

Frontiers in Pharmacology

doi 10.3389/fphar.2023.970457

4,348 views
5 citations

Case Report

Published on 03 Feb 2023

Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report

in Pharmacology of Anti-Cancer Drugs

Xuesong Chen
Wangjian Zha
Mei Su
Nan Meng
Shuliang Cao
Beifang Niu
Xu Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1053805

3,515 views
2 citations

Original Research

Published on 03 Feb 2023

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia

in Pharmacology of Anti-Cancer Drugs

Yuan-Yuan Shi
Zeng-Yan Liu
Gui-Xin Zhang
Yi He
Ming-Zhe Han
Si-Zhou Feng
Rong-Li Zhang
Er-Lie Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1014306

2,512 views
1 citation

Case Report

Published on 02 Feb 2023

Case report: Savolitinib induced severe adverse reactions resembling septic shock in an HIV-1–positive patient with advanced non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Ye Xiong
Qing Cao
Yongzheng Guo
Xiang Liu
Xueling Zhu
Bohao Dai
Biao Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1089184

2,091 views
3 citations

Navigation group

Articles

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology

Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer

Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer

Editorial: Combating cancer with natural products: Non-coding RNA and RNA modification

Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma

Nucleolin recognizing silica nanoparticles inhibit cell proliferation by activating the Bax/Bcl-2/caspase-3 signalling pathway to induce apoptosis in liver cancer

Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction

A systematic and comprehensive analysis of T cell exhaustion related to therapy in lung adenocarcinoma tumor microenvironment

Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy

Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia

Case report: Savolitinib induced severe adverse reactions resembling septic shock in an HIV-1–positive patient with advanced non-small cell lung cancer